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Impact of Biotechnology on Agriculture Productivity 
ROGER A. KLEESE 
Molecular Genetics, Inc., 10320 Bren Road East, Minnetonka, Minnesota 55343 
Biotechno~ogy is a. div_erse array of technolog_ies which today are in various stages of evolution and development. To understand them and 
~he potennal apphcanon of th~se technologies to agriculture, it is helpful to consider them in a historical perspective. In addition, it is 
important to un?erstand the mterdependence of biotechnologies on traditional, well developed technologies. 
_The commercial development of biotechnology is more difficult than imagined even as recently as five years ago. Also, the problems 
bemg addressed generally deman? a n:iuc? _better underst~nding_ of the physiology and biochemistry of the plant and animal systems 
under study. Nonetheless, there is a sigmfICant opportumty to impact production per seas well as lowering costs of production and 
creating products with added value. 
INDEX DESCRIPTORS: Agricultural biotechnology, commercial development, productivity research 
Biotechnology has been given tremendous publicity and promo-
tion. In fact, no other technology has been given the fanfare with a 
promise to deliver so much, while yet in its infancy, as biotechnology. 
This attention and these promises have attracted venture capital and 
the interest of the Wall Street community. Over two hundred start up 
biotech companies have emerged, most of them since 1978. This has 
brought about an interesting mix of scientists and business people 
often resulting in scientists with no previous business experience 
becoming the business executives. 
INVESTMENT IN BIOTECHNOLOGY RESEARCH 
The business plans (which have varied in quality and depth) have 
ranged from seeds to animal agriculture to industrial enzymes to 
artificial sweeteners to human therapeutics, with the latter category 
attracting the most attention. The diversity of the technologies 
coupled with the diversity of applications have made it difficult to 
follow and to understand these new businesses. Nonetheless, the 
public has clamored for stock in many of these companies, with public 
offerings raising over a billion dollars. 
In addition to the start up firms, large corporations have also 
invested heavily in biotechnology. These have been primarily the 
human pharmaceutical and ag chemical companies and a few of the 
larger seed companies. My point in detailing the above activity is to 
indicate to you the tremendous commercial interest in these tech-
nologies. However, I want to make it clear that the research giving rise 
to biotechnologies began in academic institutions and it continues to-
day. Federal research funding has emphasized these areas as evidenced 
by grants from National Science Foundation (NSF), National Insti-
tutes of Health (NIH), Department of Energy (DOE), Department of 
Defense (DOD), and the United States Department of Agriculture 
(USDA). Scientific publications abound with entire journals devoted 
to these subjects. Universities have been active in establishing 
curriculum majors, institutes or centers with the objective of provid-
ing focus and organization for biotechnology teaching and research. 
Chairs in molecular biology are now found at several universities. One 
can attend a large number of an ever increasing spectrum of biotech-
nology conferences. Research in both the public and private sector 
continues to be stimulating and exciting. 
BIOTECHNOLOGY - DEFINING RESEARCH AREAS 
Biotechnology is not a precise term, in fact, there is not a good term 
which embraces and defines the family of technologies. Traditional 
fields of biology such as medicine or plant and animal breeding can 
certainly be understood as biotechnologies, but generally are not 
included under the modern day umbrella of biotechnology. For our 
purposes I would like to include three sets of technologies. These three 
technologies are genetic transformation, monoclonal antibodies and 
plant cell and tissue culture. The common thread which runs through 
these three technologies is the genetic manipulation made possible by 
them. Each of the technologies gives rise to a broad range of 
applications. 
Genetic Transformation 
The first technology is dependent upon molecular biology, espe-
cially cloning of genes and their transfer to new organisms. This 
technology has been made possible by the discovery of a family of 
enzymes which can be used in a precise fashion to remove pieces of 
DNA (deoxyribonucleic acid). A skilled molecular biologist can use 
these enzymes as scissors and glue to cut apart a strand of DNA and 
insert new pieces between the cut ends. Thus, the term recombinant 
DNA. Initial work with recombinant DNA was reported in 1973. 
Since the genetic code is essentially universal, it is theoretically 
possible to identify and remove a gene from one organism and to place 
it into another. In addition to the actual insertion and manipulation of 
the new gene, it's also possible to modify the level of expression of that 
gene. One can obtain extremely high levels of expression of a cloned 
gene resulting in tremendous amounts of gene product being made. 
Many of the commercial applications play on the high level of 
expression of a foreign gene generally placed in a bacterium. The 
bacterium becomes a factory for the production of the new gene 
product. For example, human insulin and human growth hormone 
come from E. coli that has been transformed with either the human 
insulin gene or the human growth hormone gene, respectively. 
Monoclonal Antibodies 
The second technology, which I would include under the umbrella 
of biotechnology, is the making of monoclonal antibodies, known as 
hybridoma technology. When an animal's immune system is chal-
lenged by something foreign such as during infection or by a 
vaccination, a whole host of antibodies is produced. The entity 
stimulating the immune system is referred to as an antigen or an 
immunogen. Antigens are typically protein, but they could be other 
molecules of various composition. Although a variety of antibodies 
with varying degrees of specificity are produced in response to an 
antigenic stimulation, the particular cells producing antibody are 
each quite specific in the kind of antibody being made. Thus, the 
range of antibodies comes from a range of cells each producing a single 
kind of antibody. It's possible to isolate these individual cells and to 
fuse them with long living cells, generally myeloma cells, creating 
what we call hybridomas. Each hybridoma has the ability to produce a 
single kind of antibody and if one searches through the range of 
hybridomas that come from a single antigenic response one finds 
certain hybridomas which produce extremely specific antibodies. 
These antibodies, referred to as monoclonal antibodies, have a variety 
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of uses because of their specificity. Among those uses are diagnostics 
and therapeutics for specific diseases and certain chemical or industrial 
purification applications. Monoclonals were first reported in 1975. 
Plant Cell and Tissue Culture 
The third technology which I am including is th of plant cell and 
tissue culture. This is by far the oldest of the three technologies. In 
fact, the earliest literature reports of growing plant cells in culture are 
found just before the turn of the century in the late 1890s. Tissue 
cultures have been used for a number of years to propagate ornamen-
tals such as orchids, and to clean up virus infections in vegetatively 
propagated crop species such as woody ornamentals or berry plants. 
Tissue cultures are now being used in a variety of ways including 
selecting for useful traits and as recipient cells for gene transfer. Cell or 
tissue culture manipulations are very species dependent. It's possible 
to grow some species as individual cells and to regenerate whole plants 
from those cells whereas other species are difficult to maintain even as 
clumps of cells. We find in general that the cereals have been difficult 
to culture and especially difficult to manipulate as individual cells. 
The opposite is true for such species as tobacco or carrots in which any 
part of the plant can be cultured and regenerated into plants. 
EFFICIENCY OF AGRICULTURAL PRODUCTION 
I will return to a further discussion of these biotechnologies, what 
they are and what they are not, and especially their relationships with 
traditional fields of science. I want to turn now to a brief consideration 
of agricultural productivity. I would like us to think in terms of 
efficiency of agricultural production which some are referring to as 
productivity rather than simply thinking of production per se. 
Because of where you reside, I am sure you're well aware of the 
financial crisis faced by many Iowa farmers and local businesses selling 
to those farmers. There are several reasons for this including global 
recession in the past five or six years as well as the rising value of the 
dollar, both of which have resulted in decreasing demand for U.S. 
farm commodities abroad. In the midst of this we have produced in 
excess of the demand, and overproduction, especially of corn, wheat 
and soybeans, has become a major problem. An immediate reaction to 
this by some is to reduce spending for agricultural research. I think 
this would be a mistake. I will not use this time to deal with policies of 
agricultural research, but I do want you to know that my premise for 
the comments that I will make is that increasing efficiency of 
production generates a positive economic impact for society. The 
United States has a preeminence in world agriculture which has come 
from research leading to more productive biological, chemical and 
mechanical technologies coupled with more efficient managerial 
skills. We should support good agricultural research which will 
benefit both consumers and producers. This requires that we think 
rather broadly as we define the agricultural research mission. It's 
important to be aware of both national and international economic 
forces. We do market products in a world economy. We need to 
provide some protection for our own production capacity. It is 
necessary, also, to be sure that agricultural research is concerned about 
the health and safety of agricultural producers and the consumers. 
Furthermore, the environment and the quality oflife in rural areas also 
should be considered in the agricultural research mission. 
BIOTECHNOLOGY - ITS UNIQUE QUALITIES 
I would like to return now to a further discussion of biotechnology, 
what it is and what it is not, and its relationship to other areas of 
science. Much about these new technologies is not unique. Today they 
may be thought of simply as the new technologies which may some 
day be added to an impressive list of proven agricultural technologies. 
This list includes hybrid seeds, especially corn, the agricultural 
chemicals, herbicides and insecticides, and commercial fertilizers. 
Contributions from biotechnology will have to be sizable before 
adding it to this list. 
Crossing Species Boundaries 
The ability to genetically cross species barriers is one of the more 
unique properties. Plant breeders are generally constrained by work-
ing either within the crop species which they are trying to improve or 
at best using some very closely related relatives as sources of important 
genes such as those that might provide resistance to plant diseases. For 
example, it has been possible to cross closely related grass species to 
some of the cereals. Even interspecific crosses between cereals such as 
wheat and barley are possible, although it is not possible to cross either 
of those species with corn, also a cereal. Genes from broadleaf crop 
species such as tomatoes, potatoes and soybeans have not been 
available for cereal crop breeders. Using molecular biology tech-
niques, it is possible to identify genes in any species, plant or 
otherwise, and to transfer them into a new plant species. We are still 
quite limited in the range of species where this is possible. Also, we're 
limited in our ability to isolate genes. Gene transfer in most farm 
crops species has not been accomplished, but we presume that the 
technology will be developed. 
Expression of Valuable Genes 
A second unique feature of the new biotechnology is the opportuni-
ty it affords us to bring about high levels of expression of valuable 
genes. I have previously made reference to two examples of this, 
human insulin and human growth hormone. Examples in animal 
agriculture are bovine growth hormone, which causes increased milk 
production, as well as certain antiviral or immune stimulating agents 
such as the interferons. In theory, any gene could be made to express 
high levels of its gene product. 
Unique Business Opportunities 
I believe another unique characteristic of biotechnology will be the 
opportunity to cross traditional agricultural business areas. I'd like to 
give a couple of examples of this. Using either selections in plant 
tissue culture or molecular biology approaches, it is possible to 
manipulate biochemical composition such as protein quality. Proteins 
are composed of some twenty different amino acids, ten of which are 
considered essential to swine and poultry. That is, swine and poultry 
cannot make these amino acids. To formulate a balanced ration for 
either group of livestock, it is necessary to supplement corn with 
another source of protein, usually soybean oil meal, since corn protein 
is deficient in two essential amino acids, lysine and tryptophan. 
Improving protein quality in corn impacts the feed supplement 
business by reducing the need for soybean oil meal. Seed would be 
used to deliver improved protein quality and essentially to deliver the 
balanced ration. 
Another example of merging different businesses involves the use of 
seeds to deliver animal biologicals. Viruses are composed of a core of 
DNA surrounded by a coat of several proteins. When the virus invades 
an animal, the animal's immune system responds by producing 
antibodies generally against one or two predominant proteins found in 
the coat of the virus. It is, in fact, possible to stimulate good antibody 
production by simply injecting an animal with the viral protein which 
raises the protective immunologic response. The molecular biology 
approach to creating a vaccine is to isolate a gene which codes for the 
immunogenic protein, transfer that gene into a cell type which will 
serve as a factory to manufacture large quantities of the gene product 
and then to isolate the protein for use as the vaccine. An extension of 
this technology would be to remove the viral gene which codes for the 
immunogenic protein and place that directly in a plant cell. If those 
plant cells were the cells of a kernel of corn, we could imagine corn 
serving as the delivery vehicle for an oral animal vaccine. Consider 
crop plants for delivering not only vaccines, but improved nutritional 
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quality of protein, of c~r~hydrate or fut, as well as hormones which 
would enhance feed effK1ency and carcass quality. 
TRADITIONAL BIOLOGICAL RESEARCH 
SUPPORTS BIOTECHNOLOGY 
Applicati~~s of biotechnology are very dependent upon our knowl-
edge m tradmonal areas of science. We have tended to focus on the 
te~hnologies per se rat_her than thinking of the supporting fields of 
soence that are essennal for the applications that we would like co 
mak~. Even my comments have focused on the technologies, and 
certa_mly n:ost of what ~ou read would cause you to think only of the 
man1pulat1ve technologies and not of the traditional areas of science 
that must support these applications. To illustrate this, I would like to 
refer to Ol.~r own company's experience in applying some of these new 
technologies. We have both a plant biology and animal health care 
research organization. 
Plant Biology 
. Within the plant research group we have people trained in cell and 
tissue culture, as well as people who have strong backgrounds in 
molecular_biol_ogy. We think of both of these as genetic manipulative 
technologies smce they are really skills with a whole host of practices 
and procedures for manipulating plant cells or individual genes. But 
no one in our group in the course of their formal education majored in 
cell culture nor in molecular biology. Instead, the scientists' back-
grounds are in biochemistry, physical biochemistry, genetics, physiol-
ogy and microbiology. One of the projects we have pursued is the 
improvement of protein quality in corn by elevating the levels of 
lysine and tryptophan. Our approach for doing this has been to select 
for high levels of these amino acids in cell cultures in much the same 
way that a microbiologist would select for a particular mutant by 
plating millions of cells (Hibberd, et al., 1986). There is a consider-
able amount of skill and experience needed to manipulate plant cells 
in culture. It's not a trivial exercise and it's far more complex than 
growing bacteria or yeast. But even before one can consider the actual 
manipulations of the cultures, there has to be a selection strategy 
which is based upon an understanding of the biochemistry of the 
system under selection. It has been the understanding of the biosyn-
thetic pathway for tryptophan which allowed us to do our selection 
work, to know there is an enzyme which can be deregulated and in so 
doing should lead to an overproduction of tryptophan. 
Animal Biology 
In our animal health research group the principal biotechnologies 
which we have are the cloning, transfer and expression of genes and 
the isolation of monoclonal antibodies. Our commercial interests are 
in dealing with infettious diseases and in promoting growth and 
performance in livestock. Because of this, the scientific disciplines 
that our people come from are virology, veterinary medicine, im-
munology, biochemistry, microbiology and endocrinology. We have 
not always fully realized the importance of these traditional disciplines 
as they would impact the development of products. When we opened 
our doors, one of our primary product goals was to produce vaccines to 
infectious viral diseases in livestock by using a molecular biology 
approach. We assumed that if we were able to isolate the appropriate 
viral gene coding for the best immunogen and were then able to 
transfer that into bacteria and bring about a high level of expression of 
that gene, we would have an antigen that would induce the appropri-
ate immune response. Each step of the molecular biology presented a 
considerable challenge to us. I recall a time when we had been able to 
get viral genes inserted into E. coli but were struggling with getting 
significant levels of expression. We realized that we needed several 
percent of the cell protein to be made from the viral gene. Otherwise, 
we did not have a commercially viable product. I am sure if someone 
had come to us at that time and offered to sell us "an expression vector" 
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that would gi".e high levels of expression, perhaps 5-6% protein we 
would have pa1~ dearly for it. But in time we were able to manip~late 
the co~trol reg1~ns of the g_enes so we did obtain this high level of 
expression. Havmg done this we set about to immunize, first small 
'.1n1mals and then large _ani_mals, to ascertain the degree of immunolog-
lC response and to see if, m fact, we could protect animals. We have 
found this to be a very difficult exercise and now realize there is so 
much that "':"e do no~ understand about stimulating a good immune 
response with a particular ~tigen. Basic immunology is really the 
ar~ w~ere we ~eed to focus 1f we are to use this method of producing 
effKacious vaccmes. 
NEW PRODUCTS FROM 
BIOTECHNOLOGY -THE PROMISE 
What are the promises of things to come from biotechnologies? 
Jack Doyle ( 1985) writes, "These technologies promise to remedy all 
manner ?f agricultural problems confronting every society attempting 
co_ feed itself. In raw food crops, nutritional qualities can be main-
ta11:ed or carefully improved, a wider variety of nutritionally sound 
frultS and vegetables might be possible and the threat of nutritional 
erosion through breedi~g can be overcome or eliminated. New crops 
may be genetKally designed that won't require pesticides, or which 
will use less water and make their own fertilizer. Livestock can be 
engineered to produce more and better quality meat, milk, and eggs 
o? less feed. F~m an~mals can also be helped to genetically fight off 
disease and assiste~ m other ways so they won't need antibiotics, 
hormone~, or _vaccmes. A n~w and better use of ecological pest 
controls m agriculture may reign because of better biological under-
standing made possible through biotechnology." As you can see, some 
people have great expectations for biotechnology. 
NEW PRODUCTS FROM 
BIOTECHNOLOGY - REALITY 
What, in fuct, has been the impact of these technologies on 
agriculture to date? The answer is, very little. There are several 
potential new crop varieties which have come from tissue cultures 
which appear to be spontaneous genetic changes resulting in some 
improvement in the original variety. 
Herbicide Resistance 
The rationale for developing herbicide resistant crop varieties is to 
broaden the use of a particular herbicide so it can be applied to crops 
which would otherwise be sensitive. The most positive application of 
this technology involves the use of new compounds with much lower 
toxicity where smaller quantities of the chemical are applied. There 
are several examples of using either tissue culture or molecular biology 
techniques to incorporate herbicide resistance into crop varieties. 
However, most of these are with tobacco which most scientists use as a 
model system. Only a couple of the species are of furm crops, with one 
of them being corn. Varieties of these species are still a few years from 
the market. 
Disease Resistance 
There are several laboratories using tissue culture to select for 
resistance to certain plant diseases, especially those diseases which 
produce toxins. Introducing a toxin into the media would seem to be a 
reasonably effective means of selecting for cells which are able to grow 
in the presence of that toxin, thus providing some opportunity for 
eventually selecting plants which are resistant to the disease and the 
toxin. There has been some limited success with this approach 
(Gengenbach and Green, 1975 ). Using the same cell culture selection 
technique to select resistance to diseases which do not produce toxins 
poses a somewhat more complex task. Improving disease resistance 
using molecular biology techniques is not very feasible at this point. 
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We have little information which would allow us to obtain genes 
conditioning resistance to races of plant pathogens. Even if the genes 
were available, pathologists would question whether this approach 
would be a satisfactory long-term means of delaying with a plant 
pathogen. Plant breeders have for several decades selected for resist-
ance to specific races of plant pathogens by selecting for an individual 
gene which confers resistance to a race of the pathogen. In time the 
pathogen mutates and a new virulent race evolves. This has been a 
never ending cycle and one which pathologists and plant breeders have 
attempted to avoid by breeding for some lower level of resistance 
conditioned by multiple genes and thereby reducing the opportuniry 
for a highly virulent form of the pathogen to emerge. 
Insect Resistance 
Work in the insect control area has been primarily centered on the 
Bacillus thuringiensis toxin. This work is today yet limited by the 
number of plant species which can be transformed using a molecular 
biology gene transfer technique. In general, very little is understood 
of the biochemical basis for insect resistance and as a result we're faced 
with a situation not unlike that in dealing with plant diseases, where 
we are not able to chemically identify those genes which would be 
candidates for gene transfer. 
Improved Fertilizer Efficiency 
. Perhaps one of the most widely publicized potential applications of 
b10ti:chnolo?Y to crop agriculture is genetically altering plants so they 
provide their own source of nitrogen. This would seem on the surface 
to be especially useful for cereals where nitrogen is the nutrient of 
greatest need. However, there are rather major problems. First, there 
ru:e a number ?f genes responsible for fixing nitrogen. The molecular 
b10logy _exerose of getting all of these genes into a package and 
transferring them en masse would be difficult. In addition, there are 
physical and chemical demands of the system such as anaerobic 
conditions required for one of the principle enzymes. 
Stress Tolerance 
. We oft~n. see st~ess t?le~ce as something which people are 
mtere.sted m 1mprovmg with b10technology. However, it has been my 
~nen~e that the stress most often faced in Midwestern agriculture 
varies with the season and the location and is quite unpredictable. ln 
some years and loca~ions _excessive moisture creates a stress problem. 
In those ~e locations m other years deficiency of water creates a 
pro~le~. H1~h temperatures may accentuate draughty conditions. 
Yet 1t 1s poss1~le to have draughty conditions without high tempera-
ture. Cool spnng temperatures are yet another stress condition. If one 
c~ defin~ the ~icular stres~ environment such as, for example, 
salme_ soils, I _believe there _is. some opportunity to manipulate 
breeding matenals so that var1et1es can be selected which withstand 
that _specific st_ress. ~o deal with more general kinds of stress 
condmons, I think, will be difficult. 
Nutritional Quality 
By using cell cultures we have been able to elevate the levels of 
tryptophan sufficiently high in some breeding materials so there 
would be no need for additional tryptophan in swine rations. Using 
the same a~proach, we have attempted to elevate the level of lysine as 
well but. without success. Over the past year and a half we have been 
attemptmg to.~ a molecular biology approach to elevate lysine. We 
feel very. ~s1t1ve about this approach and about the long term 
opportun1t1es for manipulating nutritional quality. However, there is 
a great need to understand more about the biochemistry and physiol-
ogy of the plant so we can more efficiently make these manipulations. 
LIMITATIONS TO PROVIDE NEW PRODUCTS 
In general we have a tremendous need for a greater understanding 
of basic plant biology, that is, plant biochemistry, physiology and 
genetics, which would be most helpful in understanding host patho-
gen relationships, host insect pest relationships, fertilizer nutrient 
demands of plants, the uptake and utilization of those nutrients, as 
well as the biochemical components useful in animal nutrition. I 
think it's this knowledge gap which will limit our ability to improve 
crop varieties using some of the new technologies. In contrast there 
has been at least twenty years of basic research on bacteria and 
mammals that has laid the groundwork for medical applications of 
genetic engineering. 
There is another fundamental reason why these technologies are not 
likely to impact plant agriculture as soon as they will impact 
medicine. Many of the medical applications of biotechnology involve 
the production of large quantities of a gene product. These gene 
products are to be used either as therapeutic or diagnostic reagents. 
The molecular biology objective in manipulating these genes is 
simply to elevate the expression of the gene to the highest level 
possible within the limits of the cell producing the gene product. ln 
general, the molecular biology approaches that we imagine in crop 
plants will require that the gene be expressed in the right tissue at the 
right time and in appropriate quantities to bring about the desired 
effect. Genetically engineered crop varieties will no doubt come from 
already elite crop varieties which can be thought of as rather finely 
tuned biological systems with many good qualities to which we are 
simply trying to add an additional trait. There is a significant chance 
that adding another gene for another trait could disrupt the system. 
Furthermore, it will not be easy and straightforward to regulate the 
amount, time and location of expression of the genes we choose to 
manipulate. In short, because of the end effect desired 1 believe the 
task for genetically manipulating crop varieties will be much more 
demanding than that of producing human therapeutics. 
APPLICATION TO ANIMAL AGRICULTURE 
I would like to make a few comments about four product areas in 
animal agriculture - diagnostics, therapeutics, vaccines and growth 
~ormones .. As m~ntioned previously, there are already several diagnos-
t!Cs for animal diseases based upon the use of monoclonal antibodies. 
There are dozens of monoclonal antibody based diagnostic kits on the 
n:arket for human diseases. The task of producing these diagnostic 
kits does not seem to be difficult. However, the animal markets are 
not large and it is questionable just how many will be developed 
because of the small market size. 
Monoclonals al~o hav~ been developed to be used as therapeutic 
agents to treat ammal diseases, but again, cost of goods, that is the 
cost of monoclonal antibody, may be so high that it will limit the 
number of monoclonal antibody therapeutic products. 
1:Jsing molecul~r biology to produce vaccines by cloning viral genes· 
whICh code for 1mmunogenic proteins have generally not been 
successful. Although the gene product, the immunogenic protein, 
can be s~own to h_ave exactly the same amino acid sequence as that of 
the native protem apparently three-dimensional conformational 
changes cause these proteins to be poor immunogens. Out of some 
twenty viral diseases which have been studied using this technique, 
there are only a couple where efficacious vaccines have been produced. 
Producing animal growth hormones would seem to be an area 
where the use of molecular biology will be counted as a technical 
success. Th<:re is a consid~rable amount of work proceeding on several 
of the bovme and porcme growth hormones with a number of 
~adem!c institutions ~? commercial firms pursuing their applica-
tion t_o improve f~d eff1C1ency, rate of gain and carcass quality, as well 
as mil~ production. Products from this area of research represent 
potent1ally the largest animal agriculture market and therefore, have 
attracted the most research activity. 
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BIOTECHNOLCXiY - PUBLIC VERSUS 
PRJV ATE RESEARCH 
I have attempted up to this point to give you a thumbnail sketch of 
my impressions of some of the technical aspects of biotechnology and 
how I see them impacting agricultural productivity. There are a 
number of nonscientific issues which need to be addressed because I 
believe there are other aspects of agriculture or agricultural research 
which will also be impacted by this technology. The first of these is a 
question about who will be doing the research and, in particular, what 
will be the role of public agricultural research institutions. In the past, 
particularly in the first half of the Twentieth Century, land grant 
institutions and federal researchers in the USDA provided the major 
input into improved technologies and products for agriculture. The 
agricultural extension service was a vital link in transmitting this 
information from those institutions out to the farm. Since World War 
II we've seen the growth of the hybrid seed corn industry, the use of 
commercial fertilizers has become routine, and the advent of agricul-
tural pesticides, especially herbicides, has led to their use as a common 
agricultural input. The animal health care industry has grown up 
during that time providing products for the control or prevention of 
disease such as vaccines and antibiotics, and growth performance 
products which alter metabolism thus improving feed efficiency and 
carcass quality. These have become common in the marketplace. 
Research efforts by private industry have grown tremendously during 
this time, generally with greater focus toward applying existing 
knowledge or technologies for the development of commercial prod-
ucts. Best estimates suggest the public sector accounted for 2/3 of the 
research in the early 1950's with this proportion of research shifting to 
the private sector by the early 1980's (Ruttan, 1986). The public 
agricultural research units have continued to work on a mix of so 
called basic and applied research projects. They've also assumed some 
responsibility for working in those applied areas where commercial 
incentives are not sufficient to generate private research efforts. 
The new molecular biology based technologies as well as the 
monoclonal antibody technology were given birth outside either the 
public or private agricultural research organizations. Because of this 
there is a new mix of players working on projects that many times will 
directly impact agricultural research. We find an increasing share of 
agricultural research conducted outside colleges of agriculture as well 
as increased funding in these colleges coming from sources outside the 
USDA or state appropriations to experiment stations. This new mix of 
nonland grant institutions coupled with massive investments in start 
up biotechnology firms and large corporations is creating a very 
different picture of agricultural research activity. What will be the 
interaction and communication among the various research groups? 
What restructuring will take place? How will the role of the 
agricultural experiment stations and the USDA evolve and be shaped? 
Will all this emphasis on biotechnology distract us and severely curtail 
necessary research in traditional disciplines? 
BIOTECHNOLCXiY- PUBLIC ACCEPTANCE 
A second issue is the public's comfort level with the use of these new 
technologies. Biotechnology has generated some fear and opposition 
because of its ability to take genes from one species and put them into 
another, something that nature has prevented in the past. Critics fear 
the release of particularly virulent forms of new organisms with 
unanticipated effects. They worry about the adulteration of food or 
feedstuffs from materials produced in high levels by organisms which 
have been engineered with that capability. Those involved in biotech-
nology argue that genetically modified organisms will be appropri-
ately disarmed or that we are, after all, simply dealing with natural 
genes that produce naturally occurring gene products and that, in 
fuct, there is opportunity for greater safety. An example would be in 
making plants resistant to diseases rather than developing chemicals 
to control diseases. Nonetheless, concerns have generated consider-
able federal, some state, and even some municipal activity to provide 
an appropriate regulatory framework for evaluating the safety of the 
research activity itself as well as the products being developed. At the 
federal level, a presidential commission has involved some fifteen 
federal agencies such as the Environmental Protection Agency (EPA), 
National Institutes of Health (NIH), National Science Foundation 
(NSF), the United States Department of Agriculture (USDA) and the 
Food and Drug Administration (FDA) to come up with a comprehen-
sive, yet manageable set of regulatory policies. It is not clear today 
what regulatory issues will need to be faced in gaining approval to 
work in particular research or product areas. 
BIOTECHNOLCXiY - SOCIAL AND ECONOMIC ISSUES 
Finally, there are socio-economic issues to consider because of some 
of the biotechnology derived products. We are already observing some 
of the farmer's concerns about bovine growth hormone. When 
injected into cows, this growth hormone can improve milk produc-
tion by as much as 40%. Certain dairy farmers are saying this is a risk 
to milk prices and their own financial security because of an even 
greater overproduction of milk. Those companies working on this 
product argue that the bovine growth hormone is farm operation size 
neutral. Small farmers as well as large farmers can use the product. 
Nonetheless, a group of farmers in Wisconsin have banded together 
fighting the approval of the product and taking the stand that they 
will not use it. The European Common Market is considering a 
complete ban on this and similar products. 
If milk consumption is only maintained and if this product does 
increase milk production, then it is estimated that milk prices will fall 
and the number of dairy cows and dairy farms will also decline. Which 
farmers will be most affected? How many farms will actually disap-
pear? What will be the alternative opportunities for employment for 
dislocated farmers? 
SUMMARY 
I've tried to give you some of my impressions about the nature of 
biotechnology and its possible impact on agricultural productivity as 
well as attempting to comment on some of the more significant issues 
which I think are going to be before us. We don't, at this time, know 
just how great the impact from these technologies will be. At times 
promises of new products or technologies are in excess of what the 
biotechnologies can deliver. On the other hand, there is significant 
opportunity for some revolutionary products. No doubt we will see a 
mix of products which represent slight improvements on traditional 
product concepts together with products that we have yet to conceive. 
Agriculture is changing for reasons other than biotechnology, and it's 
going to change because of biotechnology. The challenge is to 
participate in those changes and try to direct them to the benefit of 
society. 
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